A new study suggests that babies born with hypoxic-ischemic encephalopathy (HIE) that were treated with erythropoietin, a synthetic version of the hormone that stimulates red blood cell production, experienced lesser brain injuries. Researchers indicate that erythropoietin infusions coupled with hypothermia treatment contributed to fewer incidents of brain injury, as compared to children treated with hypothermia alone, and led to superior motor skills in erythropoietin-treated children after 12 months. While the researchers caution that the results are preliminary and need to be further confirmed, senior author Roberta Ballard, MD, neonatologist and professor of Pediatrics at UCSF Benioff Children’s Hospital San Francisco said, “It is clear that this therapy is safe as used in this study and there is a strong suggestion that the patients are doing better than would be expected long term.”
The following reviews from our clients do not constitute a guarantee, warranty, or prediction regarding the outcome of another legal matter. The cases mentioned in the reviews are illustrative of some of the matters previously handled by Grant & Eisenhofer involving various areas of birth injury law. These reviews are endorsements.
The following reviews from our clients do not constitute a guarantee, warranty, or prediction regarding the outcome of another legal matter. The cases mentioned in the reviews are illustrative of some of the matters previously handled by Grant & Eisenhofer involving various areas of birth injury law. These reviews are endorsements.